Warning: The NCBI web site requires JavaScript to function. more...
Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
Huang S, Li Y, Chen Y, Podsypanina K, Chamorro M, Olshen AB, Desai KV, Tann A, Petersen D, Green JE, Varmus HE.
Genome Biol. 2005;6(10):R84. Epub 2005 Sep 30.
Related citations
Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
Podsypanina K, Li Y, Varmus HE.
BMC Med. 2004 Jun 15;2:24.
Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
Oloumi A, Maidan M, Lock FE, Tearle H, McKinney S, Muller WJ, Aparicio SA, Dedhar S.
Breast Cancer Res. 2010;12(3):R38. Epub 2010 Jun 21.
Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.
Huang S, Podsypanina K, Chen Y, Cai W, Tsimelzon A, Hilsenbeck S, Li Y.
Technol Cancer Res Treat. 2006 Dec;5(6):565-71.
Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice.
Huang S, Chen Y, Podsypanina K, Li Y.
Neoplasia. 2008 Feb;10(2):118-24.
A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS.
Cancer Res. 1999 Apr 15;59(8):1869-76.
Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J, Li Y, Liu Q, Lu W, Bu G.
Oncogene. 2010 Jan 28;29(4):539-49. Epub 2009 Nov 2.
Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
Landis MD, Seachrist DD, Montañez-Wiscovich ME, Danielpour D, Keri RA.
Oncogene. 2005 Aug 4;24(33):5173-90.
Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
Shackleford GM, MacArthur CA, Kwan HC, Varmus HE.
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):740-4.
Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET.
Cancer Res. 2004 Sep 1;64(17):5973-81.
Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA.
Cancer Res. 2006 Mar 1;66(5):2691-9.
Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.
Lin TP, Guzman RC, Osborn RC, Thordarson G, Nandi S.
Cancer Res. 1992 Aug 15;52(16):4413-9.
Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
Strumane K, Rygiel T, van der Valk M, Collard JG.
J Cancer Res Clin Oncol. 2009 Jan;135(1):69-80. Epub 2008 Jul 1.
Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
BMC Cancer. 2006 Mar 14;6:58.
Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
Oncogene. 1998 May 28;16(21):2755-66.
Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM, Shackleford GM.
Oncogene. 1997 Jun 19;14(24):2985-9.
ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.
Schroeder JA, Adriance MC, McConnell EJ, Thompson MC, Pockaj B, Gendler SJ.
J Biol Chem. 2002 Jun 21;277(25):22692-8. Epub 2002 Apr 11.
Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer.
Li Y, Hively WP, Varmus HE.
Oncogene. 2000 Feb 21;19(8):1002-9. Review.
In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
Hosokawa Y, Papanikolaou A, Cardiff RD, Yoshimoto K, Bernstein M, Wang TC, Schmidt EV, Arnold A.
Transgenic Res. 2001 Oct;10(5):471-8.
Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.
Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD, Sonenshein GE.
Mol Cell Biol. 2003 Aug;23(16):5738-54.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on